跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 65,629 条关于
“Omicron BA.2”
全部
65,629
临床试验
42,705
药物
7,434
机构
1,568
资讯
13,922
4年前
FDA Restricts Sotrovimab Use Due to Omicron BA.2 Variant Resistance
去年
FDA Revokes Authorization of GSK and Vir's Sotrovimab Due to BA.2 Inefficacy
去年
Invivyd's PEMGARDA Maintains Neutralizing Activity Against Dominant XFG COVID-19 Variant
去年
FDA Limits GSK's Xevudy Authorization Due to BA.2 Variant Concerns
去年
China's ePRO Platform Monitors COVID-19 Symptoms, Adapts to Emerging Variants
去年
FDA Grants Emergency Authorization to Lilly's Bebtelovimab for COVID-19, Securing $720M Government Contract
去年
Novel Multivalent mRNA Vaccines Show Promise Against MPXV and SARS-CoV-2 in Preclinical Studies
3年前
FDA Authorizes Second Omicron Booster for High-Risk Groups, Simplifies COVID-19 Vaccine Strategy
去年
Pfizer and BioNTech Seek FDA Authorization for COVID-19 Vaccine in Young Children
2年前
Updated COVID-19 Vaccines Targeting JN.1 and KP.2 Variants Show Promise
第 1 页,共 1393 页
上一页
下一页